SLB:NYSESLB Limited Analysis
Data as of 2026-09-07 - not real-time
$57.51
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
At $57.51, SLB N.V. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. Over a rolling month the price has gained 9.7%. With RSI at 62.2 the momentum picture is approaching overbought, alongside a bullish MACD signal. Watch $50.67 as support and $60.46 as the nearer resistance level.
Valuation screens as overvalued: a P/E of 28.1 sits above the sector average of 17.8. Sell-side targets cluster 7.9% above the current quote. Revenue is growing at 5.0% on a 8.5% profit margin. The 2.05% dividend yield looks covered by current payout levels.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 37.9%, a beta of 0.73 and a maximum drawdown of 22.3%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
This one splits by horizon — buy in the near term, hold further out, at 2/10 long-term conviction.
Valuation screens as overvalued: a P/E of 28.1 sits above the sector average of 17.8. Sell-side targets cluster 7.9% above the current quote. Revenue is growing at 5.0% on a 8.5% profit margin. The 2.05% dividend yield looks covered by current payout levels.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 37.9%, a beta of 0.73 and a maximum drawdown of 22.3%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
This one splits by horizon — buy in the near term, hold further out, at 2/10 long-term conviction.
Top Market Events
Oilfield services provider SLB NYSE:SLB reported Q2 CY2026 results , but sales fell by 4.SLB Ltd SLB reports robust digital revenue growth and strategic positioning despite geopolitical headwinds in the...SLB NYSE: SLB today announced results for the second-quarter 2026.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 49.06
- MACD momentum is positive
Medium Term
1–3 yearsPositive
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 28.1 versus sector average of 17.8
- Trading above the 200-day average of 49.06
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 28.1 versus sector average of 17.8
- Analyst targets imply +7.9% versus the current price
- Dividend yield of 2.05%
Key Metrics & Analysis
Financial Health
Revenue Growth5.00%
Profit Margin8.53%
P/E Ratio28.1
ROE12.91%
ROA6.17%
Debt/Equity47.00
P/B Ratio3.3
Op. Cash Flow$6.5B
Free Cash Flow$3.0B
Industry P/E17.8
Technical Analysis
TrendBullish
RSI62.2
Support$50.67
Resistance$60.46
MA 20$54.84
MA 50$50.79
MA 200$49.06
MACDBullish
VolumeIncreasing
Fear & Greed Index94.11
Valuation
Fair Value$25.36
Target Price$62.03
Upside/Downside7.87%
GradeOvervalued
TypeBlend
Dividend Yield2.05%
Risk Assessment
Beta0.73
Volatility37.92%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.